$ 14.92
Key Takeaways
Risk factor
Good trading liquidity
Profitability factor
Very strong margins and returns
About
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative...
Company Valuation
Considering past and projected metrics, the stock is 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITDA, reasonably priced on P
Target Price
The average target price of INMD is 17 and suggests 15% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation su
